|By Marketwired .||
|August 14, 2014 06:30 PM EDT||
XI'AN, CHINA -- (Marketwired) -- 08/14/14 -- Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"), a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, will file its financial results for the second quarter of fiscal 2014 on Thursday, August 14, 2014 by close of the business day.
Conference Call Information
The Company will host a conference call on Friday, August 15, 2014 to discuss its financial results for the quarter ended June 30, 2014. Skystar's conference call will begin promptly at 7:45 a.m. EDT to review second quarter fiscal 2014 financial and operational performance. Mr. Weibing Lu, Skystar's Chairman and Chief Executive Officer, will host the call, which will be webcast live.
Webcast will be made available on the investor relations section of the Skystar corporate website at http://www.investorcalendar.com/IC/CEPage.asp?ID=173097.
Phone dial-in to the conference call will be available in North America by dialing +1 (877) 407-8031 or internationally by dialing +1 (201) 689-8031.
An audio replay of the conference call will be available approximately two hours following the conclusion of the call and for the following 30 day period. To access the replay in North America, dial +1 (877) 660-6853 or, when calling internationally, dial +1 (201) 612-7415, referencing conference ID # 13589170.
To be added to the Company's email distribution for future news releases, please send your request to [email protected].
About Skystar Bio-Pharmaceutical Company
Skystar is a China-based developer, manufacturer and distributor of veterinary healthcare and medical care products. Skystar has four product lines: veterinary medicines, probiotics, vaccines and feed additives formulated and packaged in house across several modern manufacturing and distributions facilities. Skystar's distribution network includes almost 3,000 distribution agents of which 360 are franchised stores with exclusivity agreements covering 29 provinces throughout China. For additional information, please visit http://www.skystarbio-pharmaceutical.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Certain of the statements made in the press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward-looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties and may include financial projections or information regarding the progress of new product development. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the effect of changing economic conditions in The People's Republic of China, variations in cash flow, reliance on collaborative retail partners and on new product development, variations in new product development, risks associated with rapid technological change, and the potential of introduced or undetected flaws and defects in products, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time.
Skystar Bio-Pharmaceutical Company
Director - Corporate Development & U.S. Representative
Jan. 16, 2017 09:00 PM EST Reads: 7,425
Jan. 16, 2017 08:45 PM EST Reads: 4,574
Jan. 16, 2017 08:00 PM EST Reads: 591
Jan. 16, 2017 06:45 PM EST Reads: 3,482
Jan. 16, 2017 06:00 PM EST Reads: 354
Jan. 16, 2017 05:00 PM EST Reads: 4,006
Jan. 16, 2017 03:30 PM EST Reads: 4,818
Jan. 16, 2017 03:15 PM EST Reads: 344
Jan. 16, 2017 02:30 PM EST Reads: 1,546
Jan. 16, 2017 02:15 PM EST Reads: 5,263
Jan. 16, 2017 01:45 PM EST Reads: 3,592
Jan. 16, 2017 01:30 PM EST Reads: 3,307
Jan. 16, 2017 01:00 PM EST Reads: 3,643
Jan. 16, 2017 01:00 PM EST Reads: 1,028
"There's a growing demand from users for things to be faster. When you think about all the transactions or interactions users will have with your product and everything that is between those transactions and interactions - what drives us at Catchpoint Systems is the idea to measure that and to analyze it," explained Leo Vasiliou, Director of Web Performance Engineering at Catchpoint Systems, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York Ci...
Jan. 16, 2017 12:30 PM EST Reads: 5,476